Cargando…
Paraneoplastic Syndromes in Neuro-Ophthalmology
Paraneoplastic neurological syndromes (PNS) occur in about 1 in 300 cases of cancer. The usual mechanism is that an antigen on the cancer sets off an immune response that then cross-reacts with a nervous system antigen. The presentation is usually with a subacute progressive neurological disorder. T...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795712/ https://www.ncbi.nlm.nih.gov/pubmed/36589030 http://dx.doi.org/10.4103/aian.aian_102_22 |
_version_ | 1784860320761643008 |
---|---|
author | Hickman, Simon J. |
author_facet | Hickman, Simon J. |
author_sort | Hickman, Simon J. |
collection | PubMed |
description | Paraneoplastic neurological syndromes (PNS) occur in about 1 in 300 cases of cancer. The usual mechanism is that an antigen on the cancer sets off an immune response that then cross-reacts with a nervous system antigen. The presentation is usually with a subacute progressive neurological disorder. The management of these conditions is usually of both the underlying tumor and immunomodulation to suppress the autoimmune response. There are a number of these conditions that can present to the Neuro-Ophthalmology clinic, either as a discrete condition affecting vision or eye movements or as part of a more widespread neurological disorder. This article will discuss these conditions, their management and prognosis. |
format | Online Article Text |
id | pubmed-9795712 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-97957122022-12-29 Paraneoplastic Syndromes in Neuro-Ophthalmology Hickman, Simon J. Ann Indian Acad Neurol Neuro-Ophthalmology Supplement Paraneoplastic neurological syndromes (PNS) occur in about 1 in 300 cases of cancer. The usual mechanism is that an antigen on the cancer sets off an immune response that then cross-reacts with a nervous system antigen. The presentation is usually with a subacute progressive neurological disorder. The management of these conditions is usually of both the underlying tumor and immunomodulation to suppress the autoimmune response. There are a number of these conditions that can present to the Neuro-Ophthalmology clinic, either as a discrete condition affecting vision or eye movements or as part of a more widespread neurological disorder. This article will discuss these conditions, their management and prognosis. Wolters Kluwer - Medknow 2022-10 2022-03-25 /pmc/articles/PMC9795712/ /pubmed/36589030 http://dx.doi.org/10.4103/aian.aian_102_22 Text en Copyright: © 2022 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Neuro-Ophthalmology Supplement Hickman, Simon J. Paraneoplastic Syndromes in Neuro-Ophthalmology |
title | Paraneoplastic Syndromes in Neuro-Ophthalmology |
title_full | Paraneoplastic Syndromes in Neuro-Ophthalmology |
title_fullStr | Paraneoplastic Syndromes in Neuro-Ophthalmology |
title_full_unstemmed | Paraneoplastic Syndromes in Neuro-Ophthalmology |
title_short | Paraneoplastic Syndromes in Neuro-Ophthalmology |
title_sort | paraneoplastic syndromes in neuro-ophthalmology |
topic | Neuro-Ophthalmology Supplement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9795712/ https://www.ncbi.nlm.nih.gov/pubmed/36589030 http://dx.doi.org/10.4103/aian.aian_102_22 |
work_keys_str_mv | AT hickmansimonj paraneoplasticsyndromesinneuroophthalmology |